Determinants for successful smoking cessation with bupropion in daily practice

Pharmacy World and Science

Volumn 25, Issue 5, 2003, Pages 207-211

  Bouvy, Marcel L ^a   Buurma, Henk ^a   Egberts, Antoine C G ^b,c  

^a SIR Institute for Pharmacy Practice and Policy   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c GGZ Midden Brabant   (Netherlands)

Author keywords

Bupropion; Clinical practice; Smoking cessation

Indexed keywords

AMFEBUTAMONE;

ABSTINENCE; ADOLESCENT; ADULT; ARTICLE; CHILD; CIGARETTE SMOKING; CLINICAL PRACTICE; DRUG USE; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NETHERLANDS; REIMBURSEMENT; RETROSPECTIVE STUDY; SMOKING CESSATION; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PHARMACISTS; RETROSPECTIVE STUDIES; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0141885430     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025892031198     Document Type: Article

References (14)

1. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000; 321: 355-8.
2. Baillie AJ, Mattick RP, Hall W. Quitting smoking: estimation by meta-analysis of the rate of unaided smoking cessation. Aust J Public Health 1995; 19: 129-31.
3. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155: 1933-41.
4. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation (Cochrane Review). Cochrane Database Syst Rev 2000; 4.
5. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337: 1195-202.
6. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-91.
7. Muir J, Lancaster T, Fowler G, Neil A. Community based heart health promotion project in England. Self reporting overestimates smoking cessation rates. BMJ 1998; 316: 704-5.
8. Osler M, Gerdes LU, Davidsen M, Bronnum-Hansen H, Madsen M, Jorgensen T et al. Socioeconomic status and trends in risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992. J Epidemiol Commun Health 2000; 54: 108-13.
9. Crampton P, Salmond C, Woodward A, Reid R Socioeconomic deprivation and ethnicity are both important for anti-tobacco health promotion. Health Educ Behav 2000; 27: 317-27.
10. Connor SK, McIntyre L. The sociodemographic predictors of smoking cessation among pregnant women in Canada. Can J Public Health 1999; 90: 352-5.
11. Cavelaars AE, Kunst AE, Geurts JJ, Crialesi R, Grotvedt L, Helmert U et al. Educational differences in smoking: international comparison. BMJ 2000; 320: 1102-7.
12. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002; 288: 1260-4.
13. Ward KD, Klesges RC, Zbikowski SM, Bliss RE, Garvey AJ. Gender differences in the outcome of an unaided smoking cessation attempt. Addict Behav 1997; 22: 521-33.
14. Wee CC, Rigotti NA, Davis RB, Phillips RS. Relationship between smoking and weight control efforts among adults in the united states. Arch Intern Med 2001; 161: 546-50.